Comment on 'Impact of performance status on non-small cell lung cancer patients with a PD-L1 tumour proportion score ?50% treated with front-line pembrolizumab' için istatistikler
Toplam ziyaret
views | |
---|---|
Comment on 'Impact of performance status on non-small cell lung cancer patients with a PD-L1 tumour proportion score ?50% treated with front-line pembrolizumab' | 0 |
Aylık toplam ziyaret
views | |
---|---|
Ekim 2024 | 0 |
Kasım 2024 | 0 |
Aralık 2024 | 0 |
Ocak 2025 | 0 |
Şubat 2025 | 0 |
Mart 2025 | 0 |
Nisan 2025 | 0 |